Complement-mediated kidney diseases (CMKDs) are a group of ultra-rare, heterogenous, progressive diseases associated with poor outcomes and significant impacts on patient quality of life. Approximately half of patients with CMKDs progress to end-stage kidney disease within several years of diagnosis. Thus, early recognition is critical to achieving timely diagnosis and treatment initiation to slow disease progression. Don’t miss the chance to hear from two leading nephrologists as they discuss patient characteristics and clinical presentations that should raise the suspicion of CMKDs, and prognostic indicators of disease progression. You’ll also have an opportunity to hear real-world insights on the burden of the disease from a patient living with C3 glomerulopathy. Download the accompanying CMKD Diagnostic Evaluation Quick Reference Guide to help you and your team recognize patients requiring evaluation for CMKDs and efficiently work through a differential diagnosis.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/advancing-early-diagnosis-cmkds-expert-approaches-patient-perspectives
- Start Date: 2024-11-26 06:00:00
- End Date: 2024-11-26 06:00:00
- Credit Details: IPCE Credits: 0.25 hours
AAPA Category 1 Credit™️: 0.25 hours
AMA PRA Category 1 Credit™️: 0.25 hours
Nursing: 0.25 hours
Pharmacy: 0.25 hours - Commercial Support: Source: Novartis Corporation Pharmaceuticals - Amount: 44916.67 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all